Table 2.

Values of NLR, PLR, and Hb/RDW in 180 patients with nasopharyngeal cancer.

Indicators	N	Hb/RDW	P	NLR	P	PLR	P
Stage
I+II	84	989.87 ± 166.42	.152	2.67 ± 1.73	.043	147.53 ± 57.28	.424
III+IV	96	967.02 ± 171.00		3.27 ± 2.37		170.05 ± 98.92
Serosal invasion
T1+T2	56	1004.26 ± 142.69	.182	2.57 ± 1.68	.055	136.68 ± 50.03	.031
T3+T4	124	965.68 ± 178.58		3.18 ± 2.26		169.87 ± 92.15
Lymph node metastasis
Absence	84	985.20 ± 165.48	.301	2.66 ± 1.74	.030	146.80 ± 57.40	.313
Presence	96	971.11 ± 172.23		3.28 ± 2.36		170.69 ± 98.71
Distant metastasis
Absence	171	983.11 ± 166.97	.065	2.98 ± 2.13	.570	158.43 ± 79.29	.745
Presence	9	874.65 ± 180.30		3.25 ± 1.81		180.71 ± 137.72

P value was analyzed by the Kruskal–Wallis H test or the Wilcoxon rank-sum test.

Hb/RDW = hemoglobin-to-red cell distribution width ratio (Hb/RDW), NLR = neutrophil-to-lymphocyte ratio, PLR = platelet-to-lymphocyte ratio.